Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Regen Biopharma, Inc. (RGBPP)

  • SEC News
  • Jan. 13, 2026, 11:03 UTC
  • 8
  • 0 comments

New Form QUALIF - Regen BioPharma Inc Filed: 2026-01-12 AccNo: 9999999994-26-000013 Size: 1 KB

Comment Full text

MITESCO, INC. (MITI)

  • SEC News
  • Jan. 13, 2026, 11:03 UTC
  • 8
  • 0 comments

New Form 424B3 - Mitesco, Inc. Filed: 2026-01-13 AccNo: 0001185185-26-000117 Size: 1 MB

Comment Full text

Dynatronics Corp. (DYNT)

  • Technical Exchange News
  • Jan. 13, 2026, 10:42 UTC
  • 7
  • 0 comments

Grey symbol attribute type Security_Name was changed. Previous value: CLIENTELE LTD. New value: DYNATRONICS CORP.

Comment Full text

HC Surgical Specialists Limited (1B1)

  • SEC News
  • Jan. 13, 2026, 09:44 UTC
  • 9
  • 0 comments

Mandatory Cash Dividend/ Distribution:

Comment Full text

HC Surgical Specialists Limited (1B1)

  • SEC News
  • Jan. 13, 2026, 09:40 UTC
  • 9
  • 0 comments

General Announcement: Press release

Comment Full text

HC Surgical Specialists Limited (1B1)

  • SEC News
  • Jan. 13, 2026, 09:38 UTC
  • 8
  • 0 comments

Financial Statements and Related Announcement: Half Yearly Results

Comment Full text

FDA approves FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE from RESPIRENT PHARMS

  • FDA Approval
  • Jan. 13, 2026, 09:37 UTC
  • 27
  • 0 comments

Final approval of ANDA #ANDA #214464 for FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE. Decision date: 01/12/2026

Comment Full text

FDA updates labeling for METHYLPHENIDATE HYDROCHLORIDE

  • FDA Approval
  • Jan. 13, 2026, 09:37 UTC
  • 27
  • 0 comments

Labeling changes approved for ABHAI LLC. Active ingredient: METHYLPHENIDATE HYDROCHLORIDE. Decision date: 01/09/2026

Comment Full text

FDA updates labeling for OXYCODONE HYDROCHLORIDE

  • FDA Approval
  • Jan. 13, 2026, 09:37 UTC
  • 29
  • 0 comments

Labeling changes approved for VISTAPHARM LLC. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 01/06/2026

Comment Full text

FDA updates labeling for OXYCODONE HYDROCHLORIDE

  • FDA Approval
  • Jan. 13, 2026, 09:37 UTC
  • 24
  • 0 comments

Labeling changes approved for HIKMA. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 01/06/2026

Comment Full text

FDA updates labeling for OXYCODONE HYDROCHLORIDE

  • FDA Approval
  • Jan. 13, 2026, 09:37 UTC
  • 26
  • 0 comments

Labeling changes approved for NOVEL LABS INC. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 01/06/2026

Comment Full text

FDA approves SUCRALFATE from GLENMARK PHARMS LTD

  • FDA Approval
  • Jan. 13, 2026, 09:37 UTC
  • 22
  • 0 comments

Final approval of ANDA #ANDA #212141 for SUCRALFATE. Decision date: 01/05/2026

Comment Full text

Mind Medicine (MNMD)

  • Technical Exchange News
  • Jan. 13, 2026, 08:57 UTC
  • 9
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Mind Medicine (MindMed) Inc. - Common Shares. New value: Denium Therapeutics, Inc - Common Shares.

Comment Full text

iRhythm Technologies Inc (IRTC)

  • Technical Exchange News
  • Jan. 13, 2026, 08:57 UTC
  • 10
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: iRhythm Technologies, Inc. - Common Stock. New value: iRhythm Holdings, Inc. - Common Stock.

Comment Full text

Mesoblast Limited (MESO)

  • Business News
  • Jan. 13, 2026, 08:15 UTC
  • 7
  • 1 comments

Notification regarding unquoted securities - MSB

Market reaction Comment Full text
  • Previous
  • 182
  • 183
  • 184
  • 185
  • 186
  • Next

Search

News categories

  • Technical Exchange News(10877)
  • Event(2252)
  • SEC News(189198)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124560)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin